Page 9 - Viral Vector News Today

Of those genes. the therapies being developed here use harmless viruses to carry the genes, which are being paired with a form of biological switch that can be taken in tablet form. where disease is caused by a gene becoming incorrectly switched on, this treatment tries to turn it off or vice versa. when the idea of gene therapy started, one of the big issues was — how do you get those genes into people? so we and others, over the last five to ten years, have developed a new viral vector, and ...

Meiragtx is a company developing gene—therapy treatments. while gene therapy itself has existed for around two decades, scientists and researchers here are looking to progress it to the next level. traditional gene therapy works by replacing broken or faulty genes that are causing a condition with working copies of those genes. the therapies being developed here use harmless viruses to carry the genes, which are being paired with a form of biological switch that can be taken in tablet form. wh...

So we and others, over the last five to ten years, have developed a new viral vector, and were manufacturing that here to deliver the genes were delivering into the body. in addition, at meira, weve actually developed over the last seven years a totally new technology which allows us to, in the future, control how those genes that are delivered to the body are activated using pills. one of the six clinical trials taking place here is targeting an inherited eye condition called retinitis pigmento...

Gene therapy treatments. while gene therapy itself has existed for around two decades, scientists and researchers here are looking to progress it to the next level. traditional gene therapy works by replacing broken or faulty genes that are causing a condition with working copies of those genes. the therapies being developed here use harmless viruses to carry the genes, which are being paired with a form of biological switch that can be taken in tablet form. where disease is caused by a gene bec...

Researchers revisit lessons learned from the HIV pandemic in response to COVID-19.

/PRNewswire/ -- Growing prevalence of various chronic health conditions, including cancer, genetic disorders, and infectious diseases, is propelling growth...

Insights from industry Niall Dinwoodie Executive Director, Gene Therapy Manufacturing Europe Charles River Laboratories In this interview, Niall Dinwoodie, Executive Director for Gene Therapy for...

Dublin, Oct. 19, 2022 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Contract Manufacturing Market by Type of Service Offered, Type of Biologic Manufactured,...

/PRNewswire/ -- Allied Market Research published a report, titled, "Transjugular Intrahepatic Portosystemic Shunt (TIPS) Market by Device Type (Stents,...

In a recent study published in the International Journal of Infectious Diseases, researchers assessed the efficacy of coronavirus disease 2019 (COVID-19) vaccines in people living with human immunodeficiency virus (HIV).